Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RAVULIZUMAB vs REBIF: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RAVULIZUMAB vs REBIF: Safety Overview

Metric RAVULIZUMAB REBIF
Total FAERS Reports 118 1,748
Deaths Reported 11 90
Death Rate 9.3% 5.1%
Hospitalizations 89 553
Average Patient Age 48.4 yrs 46.1 yrs
% Female Patients 56.3% N/A
Manufacturer Alexion Pharmaceuticals Inc. N/A
Route INTRAVENOUS N/A